Ameritas Investment Partners, Inc. Haemonetics Corp Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 15,310 shares of HAE stock, worth $981,217. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,310
Previous 15,503
1.24%
Holding current value
$981,217
Previous $1.25 Million
4.02%
% of portfolio
0.04%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding HAE
# of Institutions
349Shares Held
55.7MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$382 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$332 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$283 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$272 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$253 Million0.06% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.29B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...